Article
In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumour.
Surgical oncology - 1 Feb 1995
Linehan D C, Peoples G E, Hess D T, Summerhayes I C, Parikh A S, Goedegebuure P S, Eberlein T J
Abstract excerpt
The proto-oncogene HER2/neu encodes for a 185 kDa transmembrane protein with extensive homology to the epidermal growth factor (EGF) receptor. We have previously shown a correlation between HER2/neu expression and the level of in vitro cytotoxicity of tumour-associated lymphocytes (TAL) versus autologous tumour. In addition, we have recently demonstrated that tumour-associated cytotoxic T-lymphocytes (CTL) from...
Topics
- Adenocarcinoma
- Antibodies, Monoclonal
- Base Sequence
- Cytotoxicity, Immunologic
- DNA, Complementary
- DNA, Neoplasm
- Female
- HLA-A2 Antigen
- Humans
- Interleukin-2
- Lymphocytes, Tumor-Infiltrating
